世界の腎臓がん診断市場予測（～2028年）：免疫組織化学、尿分析、血液化学検査、その他

• 英文タイトル：Global Kidney Cancer Diagnostics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8015 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

腎臓がん診断市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の腎臓がん診断の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 腎臓がん診断市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・免疫組織化学、尿分析、血液化学検査、その他 用途別セグメントは次のように区分されます。 ・病院、専門クリニック、その他 世界の腎臓がん診断市場の主要な市場プレーヤーは以下のとおりです。 ・Thermo Fisher Scientific、Abbott Laboratories、Illumina、Quest Diagnostics Incorporated、Roche Holding、Myriad Genetics、NeoGenomics Laboratories、NanoString Technologies、Sysmex Corporation、Rosetta Genomics 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、腎臓がん診断製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な腎臓がん診断メーカーの企業概要、2019年～2022年までの腎臓がん診断の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な腎臓がん診断メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別腎臓がん診断の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの腎臓がん診断の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での腎臓がん診断市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および腎臓がん診断の産業チェーンを掲載しています。 ・第13、14、15章では、腎臓がん診断の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific、Abbott Laboratories、Illumina、Quest Diagnostics Incorporated、Roche Holding、Myriad Genetics、NeoGenomics Laboratories、NanoString Technologies、Sysmex Corporation、Rosetta Genomics ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：免疫組織化学、尿分析、血液化学検査、その他 ・用途別分析2017年-2028年：病院、専門クリニック、その他 ・腎臓がん診断の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・腎臓がん診断のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・腎臓がん診断のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腎臓がん診断の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・腎臓がん診断の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Kidney Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Kidney Cancer Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Kidney Cancer Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunohistochemistry segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Kidney Cancer Diagnostics include Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, and Roche Holding, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Kidney Cancer Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunohistochemistry
Urine Analysis
Blood Chemistry Test
Others
Market segment by Application can be divided into
Hospitals
Specialty Clinics
Others
The key market players for global Kidney Cancer Diagnostics market are listed below:
Thermo Fisher Scientific
Abbott Laboratories
Illumina
Quest Diagnostics Incorporated
Roche Holding
Myriad Genetics
NeoGenomics Laboratories
NanoString Technologies
Sysmex Corporation
Rosetta Genomics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Kidney Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney Cancer Diagnostics, with price, sales, revenue and global market share of Kidney Cancer Diagnostics from 2019 to 2022.
Chapter 3, the Kidney Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Kidney Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Kidney Cancer Diagnostics.
Chapter 13, 14, and 15, to describe Kidney Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Kidney Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Cancer Diagnostics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immunohistochemistry
1.2.3 Urine Analysis
1.2.4 Blood Chemistry Test
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Cancer Diagnostics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Global Kidney Cancer Diagnostics Market Size & Forecast
1.4.1 Global Kidney Cancer Diagnostics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Kidney Cancer Diagnostics Sales in Volume (2017-2028)
1.4.3 Global Kidney Cancer Diagnostics Price (2017-2028)
1.5 Global Kidney Cancer Diagnostics Production Capacity Analysis
1.5.1 Global Kidney Cancer Diagnostics Total Production Capacity (2017-2028)
1.5.2 Global Kidney Cancer Diagnostics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney Cancer Diagnostics Market Drivers
1.6.2 Kidney Cancer Diagnostics Market Restraints
1.6.3 Kidney Cancer Diagnostics Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Product and Services
2.1.4 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Kidney Cancer Diagnostics Product and Services
2.2.4 Abbott Laboratories Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Kidney Cancer Diagnostics Product and Services
2.3.4 Illumina Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Quest Diagnostics Incorporated
2.4.1 Quest Diagnostics Incorporated Details
2.4.2 Quest Diagnostics Incorporated Major Business
2.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product and Services
2.4.4 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche Holding
2.5.1 Roche Holding Details
2.5.2 Roche Holding Major Business
2.5.3 Roche Holding Kidney Cancer Diagnostics Product and Services
2.5.4 Roche Holding Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business
2.6.3 Myriad Genetics Kidney Cancer Diagnostics Product and Services
2.6.4 Myriad Genetics Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 NeoGenomics Laboratories
2.7.1 NeoGenomics Laboratories Details
2.7.2 NeoGenomics Laboratories Major Business
2.7.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Product and Services
2.7.4 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 NanoString Technologies
2.8.1 NanoString Technologies Details
2.8.2 NanoString Technologies Major Business
2.8.3 NanoString Technologies Kidney Cancer Diagnostics Product and Services
2.8.4 NanoString Technologies Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Kidney Cancer Diagnostics Product and Services
2.9.4 Sysmex Corporation Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Rosetta Genomics
2.10.1 Rosetta Genomics Details
2.10.2 Rosetta Genomics Major Business
2.10.3 Rosetta Genomics Kidney Cancer Diagnostics Product and Services
2.10.4 Rosetta Genomics Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Kidney Cancer Diagnostics Breakdown Data by Manufacturer
3.1 Global Kidney Cancer Diagnostics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Kidney Cancer Diagnostics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Kidney Cancer Diagnostics
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney Cancer Diagnostics Manufacturer Market Share in 2021
3.4.2 Top 6 Kidney Cancer Diagnostics Manufacturer Market Share in 2021
3.5 Global Kidney Cancer Diagnostics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Kidney Cancer Diagnostics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney Cancer Diagnostics Market Size by Region
4.1.1 Global Kidney Cancer Diagnostics Sales in Volume by Region (2017-2028)
4.1.2 Global Kidney Cancer Diagnostics Revenue by Region (2017-2028)
4.2 North America Kidney Cancer Diagnostics Revenue (2017-2028)
4.3 Europe Kidney Cancer Diagnostics Revenue (2017-2028)
4.4 Asia-Pacific Kidney Cancer Diagnostics Revenue (2017-2028)
4.5 South America Kidney Cancer Diagnostics Revenue (2017-2028)
4.6 Middle East and Africa Kidney Cancer Diagnostics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Kidney Cancer Diagnostics Sales in Volume by Type (2017-2028)
5.2 Global Kidney Cancer Diagnostics Revenue by Type (2017-2028)
5.3 Global Kidney Cancer Diagnostics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Kidney Cancer Diagnostics Sales in Volume by Application (2017-2028)
6.2 Global Kidney Cancer Diagnostics Revenue by Application (2017-2028)
6.3 Global Kidney Cancer Diagnostics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Kidney Cancer Diagnostics Sales by Type (2017-2028)
7.2 North America Kidney Cancer Diagnostics Sales by Application (2017-2028)
7.3 North America Kidney Cancer Diagnostics Market Size by Country
7.3.1 North America Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
7.3.2 North America Kidney Cancer Diagnostics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney Cancer Diagnostics Sales by Type (2017-2028)
8.2 Europe Kidney Cancer Diagnostics Sales by Application (2017-2028)
8.3 Europe Kidney Cancer Diagnostics Market Size by Country
8.3.1 Europe Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
8.3.2 Europe Kidney Cancer Diagnostics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Kidney Cancer Diagnostics Sales by Type (2017-2028)
9.2 Asia-Pacific Kidney Cancer Diagnostics Sales by Application (2017-2028)
9.3 Asia-Pacific Kidney Cancer Diagnostics Market Size by Region
9.3.1 Asia-Pacific Kidney Cancer Diagnostics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Kidney Cancer Diagnostics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Kidney Cancer Diagnostics Sales by Type (2017-2028)
10.2 South America Kidney Cancer Diagnostics Sales by Application (2017-2028)
10.3 South America Kidney Cancer Diagnostics Market Size by Country
10.3.1 South America Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
10.3.2 South America Kidney Cancer Diagnostics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney Cancer Diagnostics Sales by Type (2017-2028)
11.2 Middle East & Africa Kidney Cancer Diagnostics Sales by Application (2017-2028)
11.3 Middle East & Africa Kidney Cancer Diagnostics Market Size by Country
11.3.1 Middle East & Africa Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Kidney Cancer Diagnostics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Kidney Cancer Diagnostics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Kidney Cancer Diagnostics
12.3 Kidney Cancer Diagnostics Production Process
12.4 Kidney Cancer Diagnostics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Kidney Cancer Diagnostics Typical Distributors
13.3 Kidney Cancer Diagnostics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---